BackTable Urology
Ep. 207 Integrating Clinical Trials into Routine Urology Practice with Dr. Behfar Ehdaie
Dr. Behfar Ehdaie
And so although I could have started that meeting saying we should treat only intermediate-risk prostate cancer, I think the data that was presented, the conversations that were had, not only allowed us to see a new perspective, maybe something we didn't consider, but it helped everyone else get on board because, frankly, they own that idea as well.
0
💬
0
Comments
Log in to comment.
There are no comments yet.